4.5 Article

Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, Research & Experimental

Complement C3a receptor-mediated vascular dysfunction: a complex interplay between aging and neurodegeneration Comment

Kanchan Bhatia et al.

Summary: The study found that endothelial C3a/C3aR signaling plays a critical role in normal, aging, and neurodegenerative mouse models. Mice lacking C3aR or treated with a C3aR antagonist showed reduced microglial reactivity and neurodegeneration, suggesting that complement inhibitors may be a therapeutic option for cerebral microvascular dysfunction.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Clinical Neurology

Reconsidering the reasons for heightened inflammation in major depressive disorder

Alish B. Palmos et al.

Summary: The study reveals that polygenic risk scores for MDD and BMI have different impacts on adulthood inflammation levels. While MDD PRS affects certain inflammatory markers, BMI has a significant positive effect on a greater number of inflammatory markers.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Article Immunology

Inflammatory cytokines, complement factor H and anhedonia in drug-naive major depressive disorder

Wei Tang et al.

Summary: The study revealed that patients with anhedonia in major depressive disorder exhibit different inflammatory characteristics compared to patients without anhedonia. Elevated plasma CFH levels may serve as a potential biomarker for anhedonia in subtyping MDD.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Review Medicine, General & Internal

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)

Anna Mosiolek et al.

Summary: Major depressive disorder is a prevalent mental illness worldwide, with more than 30% of patients not achieving remission through conventional therapy. Inflammation and disturbed neurogenesis are implicated in the pathophysiology of depression, with potential involvement of neurotrophic factors in patient recovery. The influence of antidepressants on inflammatory cytokines and neurotrophins remains inconsistent, with selective serotonin reuptake inhibitors, selective serotonin and noradrenaline inhibitors, and tricyclic antidepressants showing possible anti-inflammatory properties. Further research is needed to determine the role of inflammatory markers in predicting treatment response in MDD.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Psychiatry

Increased serum levels of complement C1q in major depressive disorder

Qian Yao et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2020)

Article Psychiatry

Is serum complement C1q related to major depressive disorder?

Jing Yang et al.

INDIAN JOURNAL OF PSYCHIATRY (2020)

Article Psychology, Clinical

Increased plasma complement factor H is associated with geriatric depression

Cheolmin Shin et al.

INTERNATIONAL PSYCHOGERIATRICS (2019)

Article Multidisciplinary Sciences

Lower synaptic density is associated with depression severity and network alterations

Sophie E. Holmes et al.

NATURE COMMUNICATIONS (2019)

Article Psychiatry

Associations between childhood maltreatment and inflammatory markers

Alish B. Palmos et al.

BJPSYCH OPEN (2019)

Review Medicine, General & Internal

Depression

Gin S. Malhi et al.

LANCET (2018)

Article Clinical Neurology

Plasma complement component 4 increases in patients with major depressive disorder

Jinxue Wei et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)

Article Psychiatry

Complement factor H and susceptibility to major depressive disorder in Han Chinese

Chen Zhang et al.

BRITISH JOURNAL OF PSYCHIATRY (2016)

Article Multidisciplinary Sciences

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Soyon Hong et al.

SCIENCE (2016)

Article Psychiatry

The pro-inflammatory profile of depressed patients is (partly) related to obesity

Richard C. Shelton et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2015)

Article Endocrinology & Metabolism

Adrenal gland volume, intra-abdominal and pericardial adipose tissue in major depressive disorder

Kai G. Kahl et al.

PSYCHONEUROENDOCRINOLOGY (2015)

Review Immunology

Complement and Its Receptors: New Insights into Human Disease

V. Michael Holers

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Article Medicine, General & Internal

Cross-national epidemiology of DSM-IV major depressive episode

Evelyn Bromet et al.

BMC MEDICINE (2011)

Article Clinical Neurology

Major depression, borderline personality disorder, and visceral fat content in women

Wiebke Greggersen et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)

Article Respiratory System

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD

Khaled Al-Shair et al.

RESPIRATORY RESEARCH (2011)

Article Psychiatry

Serum adiponectin and resistin levels in major depressive disorder

S. M. Lehto et al.

ACTA PSYCHIATRICA SCANDINAVICA (2010)

Article Neurosciences

A Meta-Analysis of Cytokines in Major Depression

Yekta Dowlati et al.

BIOLOGICAL PSYCHIATRY (2010)

Review Clinical Neurology

Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression

Lucia Carboni et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)

Review Psychiatry

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

M. Bryant Howren et al.

PSYCHOSOMATIC MEDICINE (2009)

Review Immunology

Complement regulators and inhibitory proteins

Peter F. Zipfel et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Biochemistry & Molecular Biology

The classical complement cascade mediates CNS synapse elimination

Beth Stevens et al.

Article Psychiatry

Childhood abuse and lifetime psychopathology in a community sample

HL MacMillan et al.

AMERICAN JOURNAL OF PSYCHIATRY (2001)

Review Endocrinology & Metabolism

Adipose tissue as an endocrine organ

RS Ahima et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)